LONDON, June 17, 2016 /PRNewswire/ -- Gastropharm is proud to announce that on June 10, Vivomixx®, the world's most concentrated probiotic, received approval for reimbursement on National Health Service (NHS) prescription. This approval was granted by the Advisory Committee on Borderline Substances (ACBS), who is responsible for advising on applications for food supplements.
Gastropharm is a United Kingdom based, specialist pharmaceutical company with key executives who have extensive experience in the research, development and marketing of products of clinical benefit to patients suffering from a wide range of gastrointestinal disorders. Gastropharm is marketing Vivomixx in the United Kingdom.
Vivomixx is a safe, gluten-free food supplement that can be taken daily to achieve a balanced digestive system. This specific combination and concentration of strains was invented some 20 years ago by medical doctor and professor of infectious diseases and immunology, Claudio De Simone, MD, PhD. Vivomixx contains his original formulation with 450 billion bacteria and eight carefully selected strains which has been subject to extensive research in 60 studies and over 170 scientific publications. "The NHS reimbursement approval of Vivomixx is important as it offers patients in the United Kingdom access to this highly concentrated probiotic. The specific formulation in Vivomixx has been widely studied, and represents an important therapeutic option for some patients," Dr. Anton Emmanuel, University College Hospital; National Hospital for Neurology and Neurosurgery.
Vivomixx is available in both sachets and capsules, and the NHS price for the 30 pack sachets is only £29.95, which represents a considerable saving for the NHS compared to the existing alternatives. If patients were switched to Vivomixx, NHS total savings could be as high as £500,000 a year.  Vivomixx is currently available in 15 countries throughout Europe.
For more information about the product and ordering from your country with reliable partners, visit http://www.vivomixx.co.uk. Consult with your physician for more information.